PSMA PET/CT for the Targeting of Prostate Biopsies: Additional Value over MRI?

被引：0
|
作者：
Morre, C. J. W. M. [1 ]
Boer, J. J. [1 ]
Rynja, S. P. [1 ]
Hagens, M. J. [2 ]
Noordzij, M. A. [1 ]
机构：
[1] Spaarne Gasthuis, Hoofddorp, Netherlands
[2] Antoni Leeuwenhoek Canc Inst, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-042
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [31] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer
    Tulsyan, Shruti
    Das, Chandan J.
    Tripathi, Madhavi
    Seth, Amlesh
    Kumar, Rajeev
    Bal, Chandrasekhar
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (12) : 1094 - 1102
  • [32] Comparison of Ga-68 PSMA PET/CT and Ga-68 PSMA PET/MRI with biparametric prostate MRI in terms of location and extension of primary prostate gland tumour
    Besli, L. Uslu
    Asa, S.
    Bakir, B.
    Sayman, H.
    Sager, S.
    Khosroshahi, B. Razavi
    Guner, E.
    Demirdag, C.
    Demir, M.
    Uslu, I.
    Sonmezoglu, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S535 - S536
  • [33] Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions
    Sergiu Scobioala
    Christopher Kittel
    Heidi Wolters
    Sebastian Huss
    Khaled Elsayad
    Robert Seifert
    Lars Stegger
    Matthias Weckesser
    Uwe Haverkamp
    Hans Theodor Eich
    Kambiz Rahbar
    Annals of Nuclear Medicine, 2021, 35 : 628 - 638
  • [34] Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions
    Scobioala, Sergiu
    Kittel, Christopher
    Wolters, Heidi
    Huss, Sebastian
    Elsayad, Khaled
    Seifert, Robert
    Stegger, Lars
    Weckesser, Matthias
    Haverkamp, Uwe
    Eich, Hans Theodor
    Rahbar, Kambiz
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (05) : 628 - 638
  • [35] Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/-CT, PET/-MRI and MRI in identifying malignant prostate lesions
    Scobioala, S.
    Kittel, C.
    Wolters, H.
    Elsayad, K.
    Stegger, L.
    Weckesser, M.
    Haverkamp, U.
    Eich, H. T.
    Rahbar, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S163 - S164
  • [36] The Value of Ga-68 PSMA PET /CT in Primary Staging of Prostate Cancer
    Ayan, Asli
    Alkan, Sumeyye
    Gunalp, Bengul
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [37] PSMA-negative prostate cancer and the continued value of choline-PET/CT
    Alberts, Ian
    Sachpekidis, Christos
    Fech, Viktor
    Rominger, Axel
    Afshar-Oromieh, Ali
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2020, 59 (01): : 33 - 34
  • [38] What is the added value of concurrent diagnostic CT for PSMA PET/CT imaging assessment of prostate cancer?
    Trinh, Kelly
    Habib, Ukasha
    Offit, Lily
    Mercaldo, Sarah
    Elia, Elisa Franquet
    Almeida, Renata R.
    Wang, Yingbing
    Park, Hyesun
    Vaz, Nuno Borges Ribeiro
    Jamal, Faisal
    Heidari, Pedram
    Jacene, Heather
    Chow, David
    Ng, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [39] Clinical perspectives of PSMA PET/MRI for prostate cancer
    Barbosa, Felipe de Galiza
    Queiroz, Marcelo Araujo
    Nunes, Rafael Fernandes
    Gomes Marin, Jose Flavio
    Buchpiguel, Carlos Alberto
    Cerri, Giovanni Guido
    CLINICS, 2018, 73
  • [40] PROMISE criteria in practice-The predictive value of prebiopsy PSMA-PET/CT in PET/CT-Ultrasound fusion guided prostate biopsy for men with previous negative biopsies
    Liu, Chen
    Liu, Teli
    Zhang, Zhongyi
    Zhang, Ning
    Du, Peng
    Yang, Yong
    Liu, Yiqiang
    Wang, Jing
    Yu, Wei
    Li, Nan
    Zhu, Hua
    Yan, Kun
    Yang, Zhi
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
12345